| Phase 24 trials |
|
Phase 2
|
NCT00685022 Comparator |
Jun → Aug 2003 |
asthma |
Sumitomo Pharma America, Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00685347 Comparator |
Jan → Jun 2003 |
exercise-induced bronchoconstriction |
Sumitomo Pharma America, Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00684827 Comparator |
Oct 2002 → Feb 2003 |
asthma |
Sumitomo Pharma America, Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01656811 Comparator |
Oct 2001 → Jul 2002 |
asthma |
Sumitomo Pharma America, Inc. |
Completed
|
No outcome recorded
|
| Phase 35 trials |
|
Phase 3
|
NCT00064389 Comparator |
Jan 2003 → Jul 2005 |
asthma |
Sumitomo Pharma America, Inc. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00073814 Comparator |
Dec 2002 → Jun 2003 |
asthma |
Sumitomo Pharma America, Inc. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00685425 Comparator |
Oct 2002 → Mar 2003 |
exercise-induced bronchoconstriction |
Sumitomo Pharma America, Inc. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00073827 Comparator |
May 2002 → Jan 2003 |
asthma |
Sumitomo Pharma America, Inc. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00667407 Comparator |
Nov 2000 → Aug 2002 |
acute asthma |
Sumitomo Pharma America, Inc. |
Completed
|
No outcome recorded
|
| Phase 41 trial |
|
Phase 4
|
NCT00124176 Comparator |
Apr 2004 → Feb 2006 |
status asthmaticus |
Children's Hospital of Philadelphia |
Completed
|
No outcome recorded
|